Home > Insider Trading > Filing (0001437749-24-006519)

Filing Details

Accession Number:: 0001437749-24-006519
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-03-04 21:38:18
Reporting Period:: 2024-02-29

Accepted Time:: 2024-03-04 21:38:18
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1158895	Lemaitre Vascular Inc	LMAT	Surgical & Medical Instruments & Apparatus (3841)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1365733	Jr P Joseph Pellegrino	C/O Lemaitre Vascular, Inc. 63 Second Avenue Burlington MA 01803	Chief Financial Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2024-02-29	3,461	$31.30	12,996	No	4	M	Direct
Common Stock	Acquisiton	2024-02-29	8,733	$23.56	21,729	No	4	M	Direct
Common Stock	Acquisiton	2024-02-29	5,883	$35.48	27,612	No	4	M	Direct
Common Stock	Acquisiton	2024-02-29	5,346	$37.29	32,958	No	4	M	Direct
Common Stock	Acquisiton	2024-02-29	7,031	$48.60	39,989	No	4	M	Direct
Common Stock	Acquisiton	2024-02-29	3,430	$47.19	43,419	No	4	M	Direct
Common Stock	Disposition	2024-02-29	1,979	$68.56	41,440	No	4	S	Direct
Common Stock	Disposition	2024-02-29	28,461	$69.72	12,979	No	4	S	Direct
Common Stock	Disposition	2024-02-29	6,250	$70.27	6,729	No	4	S	Direct
Common Stock	Disposition	2024-02-29	277	$71.19	6,452	No	4	S	Direct
Common Stock	Disposition	2024-02-29	2	$0.00	6,450	No	4	M	Direct
Common Stock	Acquisiton	2024-02-29	2,649	$0.00	9,099	No	4	A	Direct
Common Stock	Acquisiton	2024-02-29	6	$0.00	9,105	No	4	M	Direct
Common Stock	Disposition	2024-02-29	296	$70.00	8,809	No	4	F	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	M	Direct
No	4	A	Direct
No	4	M	Direct
No	4	F	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2024-02-29	3,461	$0.00	3,461	$31.30
Common Stock	Stock Option (Right to Buy)	Disposition	2024-02-29	8,733	$0.00	8,733	$23.56
Common Stock	Stock Option (Right to Buy)	Disposition	2024-02-29	5,883	$0.00	5,883	$35.48
Common Stock	Stock Option (Right to Buy)	Disposition	2024-02-29	5,346	$0.00	5,346	$37.29
Common Stock	Stock Option (Right to Buy)	Disposition	2024-02-29	7,031	$0.00	7,031	$48.60
Common Stock	Stock Option (Right to Buy)	Disposition	2024-02-29	3,430	$0.00	3,430	$47.19
Common Stock	Dividend Equivalent Rights	Disposition	2024-02-29	7	$0.00	7	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2017-12-22	2024-12-22	No	4	M	Direct
0	2018-12-19	2025-12-19	No	4	M	Direct
2,941	2019-12-20	2026-12-20	No	4	M	Direct
5,345	2020-12-02	2027-12-02	No	4	M	Direct
7,030	2021-12-11	2028-12-11	No	4	M	Direct
10,291	2022-12-12	2029-12-12	No	4	M	Direct
20			No	4	M	Direct

Footnotes

Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.
The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $68.05 to $69.04. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $69.05 to $70.045. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $70.05 to $70.62. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
Represents shares from the release of fractional dividend equivalent rights returned to company.
These shares represent LMAT common stock acquired on February 29, 2024, upon settlement of a Performance Share Unit (PSU) award granted on December 12, 2022. The PSU award vests as follows: 25% upon determination by the Compensation Committee and the balance vests in equal annual installments from the grant date over the next three years.
Each PSU represents a contingent right to receive one share of common stock upon vesting based on the attainment of performance goals.
Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.
These shares represent shares withheld by the issuer to satisfy tax withholding obligations incurred upon the vesting of performance stock units awarded to the reporting person on December 12, 2022. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934.
This option is fully vested and exercisable.
This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining four years.
These dividend equivalent rights were released in connection with the vesting of a performance share unit (PSU) award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.